Pharmaceuticals & Biotechnology
Pharmaceuticals and biotechnologies that create synergistic solutions in treating and curing chronic and life-threatening diseases are of strong interest to Johnson & Johnson Development Corporation (JJDC). JJDC is in search of clinically validated solutions across pharmaceuticals, regenerative medicine, gene therapies, and tissue and organ engineering.
Investor Contact
-
New Brunswick, New Jersey
Roy N. DavisAsish K. Xavier, PhDDalton EinhornV. Kadir Kadhiresan, PhD
-
Silicon Valley, California
Brad Vale, PhD, DVMNiamh PellegriniScott Moonly, PhDRami Elghandour
-
Tel Aviv, Israel & Beerse, Belgium
Investment Criteria
JJDC investments have stringent selection criteria and are supported with validated data and research. Johnson & Johnson Development Corporation is interested in venture business opportunities that have large addressable markets, clear competitive advantages, IP protection, an executable clinical and commercialization plan, and are led by experienced management.
